questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of Enhertu in reducing the number of women who lose their lives to breast cancer in (a) Newcastle-under-Lyme constituency and b) England.
answerText: Whilst we have made no specific assessment, the clinical trial evidence considered by the National Institute for Health and Care Excellence (NICE) shows that Enhertu increases how long people live and how long they have before their cancer gets worse comp...
heading: Trastuzumab Deruxtecan